Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SyAqua is a leading aquaculture biotechnology company specializing in the genetic improvement and nutritional optimization of shrimp, particularly Litopenaeus vannamei. The company leverages advanced genomic selection and breeding technologies to produce high-performance broodstock that exhibit superior growth rates and disease resistance. Beyond genetics, SyAqua provides specialized hatchery feeds and health products designed to improve survival and productivity in shrimp farming. Headquartered in Thailand with a global presence, the company serves major aquaculture markets across Asia and the Americas. SyAqua is recognized for its Specific Pathogen Free (SPF) facilities and its data-driven approach to sustainable aquaculture.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SyAqua.